Adiponectin is one of important proteins involved in NAFLD pathogenesis and it exhibits anti-inflammatory actions by blocking NF-κB and lowering the release of TNF-α, IL-6, COX-2, and iNOS. Here, ADIPOQ is linked to metabolic dysfunction-associated steatotic liver disease.